Literature DB >> 16932269

Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.

Marcello D Bronstein1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932269     DOI: 10.1038/ncpendmet0135

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


× No keyword cloud information.
  2 in total

Review 1.  Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis.

Authors:  Jintao Hu; Xin Zheng; Weihua Zhang; Hui Yang
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

2.  High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?

Authors:  Etual Espinosa-Cárdenas; Miriam Sánchez-García; Claudia Ramírez-Rentería; Victoria Mendoza-Zubieta; Ernesto Sosa-Eroza; Moises Mercado
Journal:  Endocrine       Date:  2020-06-17       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.